SCHEMBL1024113

SCHEMBL1024113

O=C(O)c1c[nH]c2ccc(Cc3cccc(Cl)c3)cc2c1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 11/20 0.61
GABRB2 P47870 11/20 0.61
GABRB1 P18505 2/20 0.58
GABRA3 P34903 2/20 0.58
F7 P08709 1/20 0.55
F3 P13726 1/20 0.55
KDM4E B2RXH2 1/20 0.53
SNCA P37840 2/20 0.50
GABRP O00591 1/20 0.49
GABRD O14764 1/20 0.49
GABRG2 P18507 1/20 0.49
GABRB3 P28472 1/20 0.49
GABRA5 P31644 1/20 0.49
GABRA2 P47869 1/20 0.49
GABRA4 P48169 1/20 0.49
GABRE P78334 1/20 0.49
GABRA6 Q16445 1/20 0.49
GABRG1 Q8N1C3 1/20 0.49
GABRG3 Q99928 1/20 0.49
GABRQ Q9UN88 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4451135 0.89 GABRA1 (0.75) GABRA1GABRB2GABRB1GABRA3KDM4E
SCHEMBL17338628 0.86 GABRA1 (0.53) GABRA1GABRB2GABRB1GABRA3SNCA
SCHEMBL4650044 0.85 GABRA1 (0.70) GABRA1GABRB2GABRB1GABRA3KDM4E
SCHEMBL17338625 0.84 GABRA1 (0.80) GABRA1GABRB2GABRB1GABRA3ALDH1A1
SCHEMBL4650038 0.82 GABRA1 (0.62) GABRA1GABRB2GABRB1GABRA3KDM4E
SCHEMBL17338606 0.82 GABRA1 (0.57) GABRA1GABRB2GABRB1GABRA3F7
SCHEMBL1019952 0.82 GABRA1 (0.53) GABRA1GABRB2GABRB1GABRA3KDM4E
SCHEMBL398364 0.81 F7 (0.81) GABRA1GABRB2GABRB1GABRA3F7
SCHEMBL4650642 0.81 KDM4E (0.72) GABRA1GABRB2GABRB1GABRA3KDM4E
Monofluoroacetamide SCHEMBL4564454 0.81 GABRA1 (0.65) GABRA1GABRB2GABRB1GABRA3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3145914-A1 AGENTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR AND INFLAMMATORY DISEASES STRUCTURALLY BASED ON 4(1 H)-QUINOLONE UCL Business PLC (GB) 2017-03-29 EP disclosed
WO-2015189560-A1 AGENTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR AND INFLAMMATORY DISEASES STRUCTURALLY BASED ON 4(1 H)-QUINOLONE UCL BUSINESS PLC (GB) 2015-12-17 WO disclosed
EP-1954274-B8 SUBSTITUTED QUINOLONES AND METHODS OF USE CHEMOCENTRYX INC (US) 2011-01-12 EP disclosed
EP-1954274-A4 SUBSTITUTED QUINOLONES AND METHODS OF USE CHEMOCENTRYX INC (US) 2009-01-07 EP disclosed
EP-1954274-A2 SUBSTITUTED QUINOLONES AND METHODS OF USE ChemoCentryx Inc (US) 2008-08-13 EP disclosed
WO-2007059108-A2 SUBSTITUTED QUINOLONES AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2007-05-24 WO disclosed